Literature DB >> 24908858

Delays in the stroke thrombolysis pathway--identifying areas for improvement.

L Brewer, C Arize, J McCormack, D Williams.   

Abstract

Despite international consensus on the benefits of thrombolysis for ischaemic stroke (IS), it remains underused. Guidelines now recommend a door-to-needle time of 60 minutes. We reviewed the rate and timeliness of thrombolysis for IS at our hospital. 323 stroke patients presented between January 2011 and April 2012.Thirty patients (10.6% of IS) were thrombolysed, mean age was 68.5 years (42 to 88) and 19 patients (63%) were male. Thirty-six patients (12.7% of IS) were not thrombolysed despite arriving within the time-window and symptom resolution was the commonest reason (15 patients; 42%). Despite most thrombolysed patients (42%) presenting to the Emergency Department during daytime working hours, there were delays at each step of the acute care pathway. The mean time for stroke team review was 23 minutes (5-50). The mean door-to-CT and the door-to-needle times were 60 minutes (25-95) and 92 minutes (46-130) respectively. In parallel with national stroke incentives, local audit can highlight barriers to uptake and efficiency within thrombolysis services.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24908858

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  2 in total

1.  A protocol to evaluate the impact of embedding Public and Patient Involvement in a structured PhD program for stroke care.

Authors:  Frances Horgan; Olive Lennon; Anne Hickey; Jan Sorensen; Thilo Kroll; Deirdre McCartan; Patricia Hall; Geraldine O'Callaghan; Clare Fitzgerald; Julianne Hickey; Martin Fahy; Philip Osborne; Mary Scullion; Clíodhna Ní Bhroin; David J Williams
Journal:  Front Rehabil Sci       Date:  2022-07-22

2.  Time to CT scan for patients with acute severe neurological symptoms: a quality assurance study.

Authors:  Pernille Pape; Alice Herrlin Jensen; Ove Bergdal; Tina Nørgaard Munch; Søren Steemann Rudolph; Lars Simon Rasmussen
Journal:  Sci Rep       Date:  2022-09-10       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.